Anatara Lifesciences Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -2.561x

Anatara Lifesciences Ltd cash flow conversion efficiency. Based on the latest financial reports, Anatara Lifesciences Ltd (ANR) has a cash flow conversion efficiency ratio of -2.561x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.37 Million ≈ $-971.13K USD) by net assets (AU$535.97K ≈ $379.23K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Anatara Lifesciences Ltd (2013–2025)

Cash flow conversion efficiency of Anatara Lifesciences Ltd from 2013 to 2025. This chart illustrates how Anatara Lifesciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ANR share price today for real-time trading data and today's change.

Anatara Lifesciences Ltd Cash Flow Conversion Ratio Explained

Anatara Lifesciences Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Anatara Lifesciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anatara Lifesciences Ltd ranked by their cash flow conversion efficiency. Also see ANR stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hitek Global Inc. NASDAQ:HKIT	-0.007x
Pineapple Financial Inc. NYSE:PAPL	0.471x
GO2 People Ltd AU:GO2	-0.007x
Savannah Energy PLC LSE:SAVE	0.060x
Sonovia Ltd TA:SONO	-1.025x
True North Gems Inc V:TGX	0.001x
Multipolar Tbk JK:MLPL	0.015x
Innovation Beverage Group Limited NASDAQ:IBG	-0.413x

Annual Cash Flow Conversion Efficiency for Anatara Lifesciences Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Anatara Lifesciences Ltd from 2013 to 2025. Review Anatara Lifesciences Ltd (ANR) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$535.97K ≈ $379.23K	AU$-2.27 Million ≈ $-1.61 Million	-4.239x	-363.73%
2024-06-30	AU$1.36 Million ≈ $965.52K	AU$-1.25 Million ≈ $-882.61K	-0.914x	+62.57%
2023-06-30	AU$924.54K ≈ $654.17K	AU$-2.26 Million ≈ $-1.60 Million	-2.442x	-49.22%
2022-06-30	AU$1.36 Million ≈ $965.33K	AU$-2.23 Million ≈ $-1.58 Million	-1.637x	-198.86%
2021-06-30	AU$3.83 Million ≈ $2.71 Million	AU$-2.10 Million ≈ $-1.48 Million	-0.548x	+42.59%
2020-06-30	AU$2.86 Million ≈ $2.02 Million	AU$-2.72 Million ≈ $-1.93 Million	-0.954x	-152.17%
2019-06-30	AU$5.92 Million ≈ $4.19 Million	AU$-2.24 Million ≈ $-1.58 Million	-0.378x	+2.02%
2018-06-30	AU$8.59 Million ≈ $6.08 Million	AU$-3.32 Million ≈ $-2.35 Million	-0.386x	-61.22%
2017-06-30	AU$12.02 Million ≈ $8.51 Million	AU$-2.88 Million ≈ $-2.04 Million	-0.239x	-1050.92%
2016-06-30	AU$13.48 Million ≈ $9.53 Million	AU$-280.37K ≈ $-198.38K	-0.021x	+94.08%
2015-06-30	AU$5.48 Million ≈ $3.88 Million	AU$-1.92 Million ≈ $-1.36 Million	-0.351x	-296.93%
2014-06-30	AU$7.23 Million ≈ $5.11 Million	AU$-639.27K ≈ $-452.32K	-0.088x	-114.01%
2013-06-30	AU$-280.65K ≈ $-198.58K	AU$-177.22K ≈ $-125.39K	0.631x	--

About Anatara Lifesciences Ltd

AU:ANR Australia Biotechnology

Market Cap

$1.40 Million

AU$1.98 Million AUD

Market Cap Rank

#30384 Global

#1775 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.01

All Time High

AU$1.64